mafosfamide has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douay, L; Fenaux, P; Gorin, NC; Isnard, F; Laporte, JP; Lesage, S; Lopez, M; Najman, A; Stachowiak, J | 1 |
| Abdallah, A; Egerer, G; Haas, R; Ho, AD; Körbling, M; Weber-Nordt, RM | 1 |
1 trial(s) available for mafosfamide and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prognosis; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
1 other study(ies) available for mafosfamide and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Feasibility Studies; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Remission Induction; Transplantation, Autologous | 1993 |